Summary
For Year 2026-27, Mono Pharmacare reports the following shareholding: Total Promoters at 56.72%, Mutual Fund at 0%, Insurance at 0%, Foreign Institutional Investors at 0%, Domestic Institutional Investors at 0%, and Retail at 43.28%. This breakdown provides a quick snapshot of ownership distribution for Mono Pharmacare in 2026-27.
Mono Pharmacare FAQs
As of 04-2026, the promoter shareholding in Mono Pharmacare stands at 56.72% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Mono Pharmacare is 0% and 0% respectively.
The retail shareholding of the Mono Pharmacare is 43.28%.
Changes in shareholding patterns of Mono Pharmacare can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Mono Pharmacare are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
